Stigma of opioid addiction barrier to improving care

INCREASED COMPETITION: Dr. Jason Spangler, foreground, executive director of medical policy and quality strategies for Amgen, speaks during the Oct. 5 PBN Health Care Summit about how Amgen is working to lower prescription drug costs by increasing competition. / PBN PHOTO/RUPERT WHITELEY
INCREASED COMPETITION: Dr. Jason Spangler, foreground, executive director of medical policy and quality strategies for Amgen, speaks during the Oct. 5 PBN Health Care Summit about how Amgen is working to lower prescription drug costs by increasing competition. / PBN PHOTO/RUPERT WHITELEY
The stigma surrounding the opioid addiction is similar to that of the AIDS epidemic in recent decades, says Dr. Martin Serota, chief medical officer for Prospect Charter­Care Health Partners. The AIDS crisis became much more manageable with the cooperation of doctors, researchers and the pharmaceutical industry, he said. “We need to do the same thing…

Subscriber-only Content

This article is available only to PBN Subscribers. To get unlimited access, please subscribe by following the link below.

Subscribe Now

Already a subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -